Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Attovia Therapeutics, Inc.

Attovia Therapeutics Announces First Participant Dosed in First-in-Human Phase 1 Study of ATTO-1310, its Novel Half-life Extended Anti-IL-31 ATTOBODY for the Treatment of Chronic Pruritus
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Attovia Therapeutics Appoints Chief Financial Officer
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers CNTB
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Tickers ORIC
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Attovia Announces Second Tranche Closing of $60 Million Series A Financing and Highlights Progress Building a Best-in-Class Pipeline Leveraging the Attobody™ Platform
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.